P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. . BMJ 2022;376:o239.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ 2022;376:o239.
PMID: 35086825